Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1548193/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841558791780302848 |
|---|---|
| author | Guangzhuang Li Sentao Xian Xianchao Cheng Yunhua Hou Wenqing Jia Yukui Ma |
| author_facet | Guangzhuang Li Sentao Xian Xianchao Cheng Yunhua Hou Wenqing Jia Yukui Ma |
| author_sort | Guangzhuang Li |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b684dc2d169d429eace386cde1b37b83 |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-b684dc2d169d429eace386cde1b37b832025-01-06T06:58:59ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.15481931548193Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulationGuangzhuang Li0Sentao Xian1Xianchao Cheng2Yunhua Hou3Wenqing Jia4Yukui Ma5School of Bioengineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, ChinaSchool of Chemistry and Chemical Engineering, Qilu Normal University, Jinan, ChinaTianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, ChinaSchool of Bioengineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, ChinaSchool of Chemistry and Chemical Engineering, Qilu Normal University, Jinan, ChinaSchool of Chemistry and Chemical Engineering, Qilu Normal University, Jinan, Chinahttps://www.frontiersin.org/articles/10.3389/fphar.2024.1548193/fullOroxylin Achronic kidney diseaserenal fibrosisSirt1molecular docking |
| spellingShingle | Guangzhuang Li Sentao Xian Xianchao Cheng Yunhua Hou Wenqing Jia Yukui Ma Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation Frontiers in Pharmacology Oroxylin A chronic kidney disease renal fibrosis Sirt1 molecular docking |
| title | Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation |
| title_full | Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation |
| title_fullStr | Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation |
| title_full_unstemmed | Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation |
| title_short | Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation |
| title_sort | corrigendum efficacy of oroxylin a in ameliorating renal fibrosis with emphasis on sirt1 activation and tgf β smad3 pathway modulation |
| topic | Oroxylin A chronic kidney disease renal fibrosis Sirt1 molecular docking |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1548193/full |
| work_keys_str_mv | AT guangzhuangli corrigendumefficacyoforoxylinainamelioratingrenalfibrosiswithemphasisonsirt1activationandtgfbsmad3pathwaymodulation AT sentaoxian corrigendumefficacyoforoxylinainamelioratingrenalfibrosiswithemphasisonsirt1activationandtgfbsmad3pathwaymodulation AT xianchaocheng corrigendumefficacyoforoxylinainamelioratingrenalfibrosiswithemphasisonsirt1activationandtgfbsmad3pathwaymodulation AT yunhuahou corrigendumefficacyoforoxylinainamelioratingrenalfibrosiswithemphasisonsirt1activationandtgfbsmad3pathwaymodulation AT wenqingjia corrigendumefficacyoforoxylinainamelioratingrenalfibrosiswithemphasisonsirt1activationandtgfbsmad3pathwaymodulation AT yukuima corrigendumefficacyoforoxylinainamelioratingrenalfibrosiswithemphasisonsirt1activationandtgfbsmad3pathwaymodulation |